Diagnostic and Therapeutic Approach to Hypercalcemia: A Mini-Review and Discussion of Cases
Endocrinology, Metabolism and Nutrition · 2022
DOI: 10.33425/2833-0307.1006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Metabolism and Nutrition, 2022. Verfasst von Adel Ekladious und 1 weiteren Autor:innen.
Abstract (Originalsprache)
She had a series of blood tests including full blood count (FBC), C reactive protein (CRP), liver function tests (LFTs), and a metabolic panel. All blood tests were unremarkable apart from corrected serum calcium which was mildly elevated at 2.7mmol/L (1.9-2.6 mmol/L). Parathyroid hormone (PTH) was checked, and it was also mildly elevated at 53 pg/ml (11-51 pg/ml). This patient was treated with IV ampicillin as well as IV normal saline. Though she improved clinically, her serum calcium remained elevated after 3 liters of IV saline. How would you further investigate this patient’s hypercalcemia?
Zitieren
APA
Ekladious, A., & Campbell, M. (2022). Diagnostic and Therapeutic Approach to Hypercalcemia: A Mini-Review and Discussion of Cases. Endocrinology, Metabolism and Nutrition. https://doi.org/10.33425/2833-0307.1006
Vancouver
Ekladious A, Campbell M. Diagnostic and Therapeutic Approach to Hypercalcemia: A Mini-Review and Discussion of Cases. Endocrinology, Metabolism and Nutrition. 2022. doi:10.33425/2833-0307.1006
BibTeX
@article{Ekladious2022,
author = {Ekladious, Adel and Campbell, Mark},
title = {Diagnostic and Therapeutic Approach to Hypercalcemia: A Mini-Review and Discussion of Cases},
journal = {Endocrinology, Metabolism and Nutrition},
year = {2022},
doi = {10.33425/2833-0307.1006}
}
EUVIMED